OVERVIEW

This program will equip clinicians to diagnose and optimally manage patients with, or at risk for heart failure.

Session 1 - August 10, 2022 – Co-chairs: Dr. Milan Gupta and Dr. Stephanie Poon

Opening Comments
What is heart failure? A new universal definition - Jonathan Howlett
Biomarkers for HF diagnosis and management- Peter Liu
The four pillars of HFrEF: Which drugs, in what order, and how quickly? - Shelley Zieroth
Vericiguat: beyond the four pillars- Milan Gupta
Recognition and management of hATTR cardiomyopathy- Margot Davis
Panel Discussion- All faculty
Closing Comments

Session 2 - August 17, 2022- Co-chairs: Dr. Milan Gupta and Dr. Nadia Giannetti

Opening Comments
Can we improve outcomes in acute decompensated HF? - Phyllis Billia
Myocarditis associated with COVID-19 infection and vaccines- Michael Chetrit
HFpEF: New treatments to improve outcomes- Nadia Giannetti
Dietary sodium - what to recommend to HF patients?- Justin Ezekowitz
Hyperkalemia: the bain of HF management - Jordan Weinstein
Panel Discussion - All faculty
Closing Comments

TARGET AUDIENCE

Primary care physicians and cardiovascular specialists.

ACCREDITATION

This program is not accredited. 

For more information please visit the official event page.